Introduction to sales restriction and lifting data of A-share listed companies
According to the "Measures for the Administration of Information Disclosure by Listed Companies", listed companies, as information disclosure obligors, should truthfully, accurately, timely and completely disclose to the market information disclosed in accordance with the law and voluntarily. This publicly disclosed information includes but is not limited to the company's basic information, major accounting data and financial indicators, shareholder shareholdings, executive compensation, etc. Information disclosure by listed companies is an important basis for government supervision and investor behavior. The combination of effective administrative supervision and market supervision has formed a dual-track effect that promotes the stable and orderly development of the securities market.
CnOpenData launches A-share listed company sales restriction and lifting data, including securities code, company abbreviation, announcement date, lifting date, circulating shares, ratio of circulating shares to total equity, shareholder name, share type, etc. field.
Time interval
2006-2022.12
Field display
| A-share listed company sales restriction and lifting data fields |
|---|
| Securities code |
| Company abbreviation |
| Announcement Date |
| Lifting date |
| Trading shares (shares) |
| Ratio of circulating shares to total equity (%) |
| Name of shareholder |
| Share Type |
Sample data
| Securities code | Company abbreviation | Announcement date | Date of lifting of ban | Trading shares | Ratio of circulating shares to total equity (%) | Name of shareholder | Share Type |
|---|---|---|---|---|---|---|---|
| 300894 | Martians | 2020-12-30 | 2021-12-31 | 6750000 | 1.6667 | Hangzhou Jintou Zhihui Venture Capital Partnership (Limited Partnership) | IPO original shares |
| 300894 | Martians | 2020-12-30 | 2021-12-31 | 14950000 | 3.6914 | Dong Qiliang | IPO original shares |
| 300894 | Martians | 2020-12-30 | 2021-12-31 | 19700000 | 4.8642 | Haining Rongpu Equity Investment Partnership (Limited Partnership) | IPO original shares |
| 300894 | Martians | 2020-12-30 | 2021-12-31 | 21300000 | 5.2593 | Ningbo Meishan Bonded Port Area Sequoia Zhisheng Equity Investment Partnership (Limited Partnership) | IPO original shares |
| 300894 | Martians | 2020-12-30 | 2021-12-31 | 37200000 | 9.1852 | Zhu Zhengyao | IPO original shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Shanxi Securities Co., Ltd. self-operated account | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Changxin Yinli Selected Hybrid Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Lingjun Investment-New One Heart Hedge No. 49 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Ping An Ruixiang Entertainment Flexible Allocation of Hybrid Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Magic Square Quantitative Neutral Exclusive No. 25 Phase 5 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Shenwanlingxin Jianxin Chuangxin No. 5 Collective Asset Management Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Ruiyuan Fund recruits Hengjian No. 4 collective asset management plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Yinye Gongyu No. 9 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Hui Yi No. 5 | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Lingjun Qingyun Index Enhanced Operation No. 2 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Zhejiang Jiuzhang Asset Management Co., Ltd.-Jiuzhang Huanfang Haoyue No. 17 Private Equity Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Invesco Great Wall Fund Sunshine View 2 Collective Asset Management Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Yangtze River Golden Wealth Creation Stock-type Pension Product-Shanghai Pudong Development Bank Co., Ltd. | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Galaxy Industry Preferred Hybrid Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Lingjun Hengwan No. 1 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Ping An Pension-Guangdong Province Qihao Occupational Annuity Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Xuanyuan Kexin No. 53 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Yifangda Ruiheng flexibly allocates hybrid securities investment funds | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | CITIC Prudential CSI 800 Pharmaceutical Index Securities Investment Fund (LOF) | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Hua Fu CSI Artificial Intelligence Industry Traded Open Index Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | One Village Exclusive No. 6 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Boyi Anying Selected No. 1 Private Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Harvest Fund-CITIC Prudential Life Relative Income Strategy Single Asset Management Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Shi Feng Asset Houji No. 6 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Zhongtai Asset Management No. 9505 Jinrui No. 5 Single Asset Management Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Guotai Anhong No. 1 Collective Asset Management Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Huatai-Bairui Peak Value Collective Asset Management Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Huashang Double Drive Preferred Flexible Allocation Hybrid Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Southern Fund Leyi stock-based pension products | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Boshi Fund Xincheng No. 3 Collective Asset Management Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Dongfeng Motor Co., Ltd. Dongfeng Nissan Passenger Car Company Enterprise Annuity Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Chuangjin Hexin Innovation-Driven Stock Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 186 | 0 | Yigu Mercury No. 8 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 1386 | 0.0003 | ICBC Ruyi Pension No. 1 Corporate Annuity Collective Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Great Wall Small and Medium Cap Growth Hybrid Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Lingjun Investment-New One Heart Hedge No. 4 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 462 | 0.0001 | Ping An Research Smart Selection Hybrid Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Magic Square Quantitative Xinhuai 1000 Index Exclusive No. 32 Phase 2 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Shenwanlingxin Jianxin Chuangxin No. 6 Collective Asset Management Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Ruiyuan Fund recruits Hengjian No. 5 collective asset management plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Yinye Xinyu Preferred Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 924 | 0.0002 | Liaoning Province No. 5 Occupational Annuity Plan | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Lingjun Qingyun Index Enhanced Operation No. 3 Private Securities Investment Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Zhejiang Jiuzhang Asset Management Co., Ltd.-Jiuzhang Huanfang Haoyue No. 19 Private Equity Fund | IPO shares |
| 301015 | Baiyang Pharmaceutical | 2021-06-22 | 2021-12-31 | 199 | 0 | Invesco Great Wall Fund Sunshine Jinghui No. 3 Collective Asset Management Plan | IPO shares |
Data update frequency
Annual Update